Results 1 to 10 of about 6,225,804 (188)

Cáncer Renal.

Revista Guatemalteca de Urología, 2018
El diagnóstico y tratamiento del cáncer renal ha cambiado de forma importante en los últimos años. La incidencia mundial ha aumentado, pero la sobrevida también ha mejorado con el diagnóstico temprano de masas renales de forma incidental, debido al uso ...
Juan Pablo Lezana Vega
doaj   +2 more sources

Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA

Molecular Cancer, 2020
Background Accumulating literatures have indicated that long non-coding RNAs (lncRNAs) are potential biomarkers that play key roles in tumor development and progression.
Wei Wang, Wentao Hu, Ya Wang, Yong An, Lei Song, Panfeng Shang, Zhongjin Yue   +6 more
doaj   +2 more sources

Experiencia en Nefrectomía Parcial y Enucleación de Tumor Renal Laparoscópico “Zero Isquemia”, en Cochabamba, Bolivia

Gaceta Médica Boliviana, 2022
Antecedentes: El manejo quirúrgico de los tumores renales pequeños es la cirugía conservadora de nefronas, este tipo de manejo se reservaba para pacientes seleccionados, con riñón solitario, enfermedad renal crónica o tumores bilaterales.
Vladimir Erik Vargas Rocha, Juan Carlos Freire Guffanti, Patricia Segales-Rojas   +2 more
doaj   +1 more source

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I

Journal of Urology, 2021
Purpose: This AUA Guideline focuses on evaluation/counseling/management of adult patients with clinically-localized renal masses suspicious for cancer, including solid-enhancing tumors and Bosniak 3/4 complex-cystic lesions.
S. Campbell, P. Clark, Sam S. Chang, J. Karam, Lesley Souter, R. Uzzo   +5 more
semanticscholar   +1 more source

PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis

International Journal of Molecular Sciences, 2023
Renal cell carcinoma (RCC) represents 85–95% of kidney cancers and is the most frequent type of renal cancer in adult patients. It accounts for 3% of all cancer cases and is in 7th place among the most frequent histological types of cancer.
S. Bădoiu, M. Greabu, D. Miricescu, Iulia-Ioana Stănescu-Spînu, Radu Ilinca, D. Balan, Andra-Elena Balcangiu-Stroescu, D. Mihai, I. A. Vacaroiu, Constantin Ștefani, V. Jinga   +10 more
semanticscholar   +1 more source

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II

Journal of Urology, 2021
Purpose: This AUA Guideline focuses on active surveillance (AS) and follow-up after intervention for adult patients with clinically-localized renal masses suspicious for cancer, including solid enhancing tumors and Bosniak 3/4 complex cystic lesions ...
S. Campbell, R. Uzzo, J. Karam, Sam S. Chang, P. Clark, Lesley Souter   +5 more
semanticscholar   +1 more source

Patient‐derived renal cell carcinoma organoids for personalized cancer therapy

Clinical and Translational Medicine, 2022
Background Kidney cancer is one of the most common solid tumors. The advancement of human kidney cancer research and treatment has been hindered by a lack of research models that faithfully recapitulate the diversity of the disease.
Zhichao Li, Hai－sheng Xu, Lei Yu, Jia Wang, Qian Meng, Hongbing Mei, Z. Cai, Wei Chen, Weiren Huang   +8 more
semanticscholar   +1 more source

Nefrectomía Parcial Laparoscópica.

Revista Guatemalteca de Urología, 2020
Actualmente la mayor parte de canceres renales se diagnostican localizados en aproximadamente 65% de los casos.  La nefrectomía parcial frente a la nefrectomía radical disminuye el riesgo de mortalidad por todas las causas en un 19% y cáncer especifica ...
Javier Flores-Carbajal, Harvey Medrano-Urtecho   +1 more
doaj   +1 more source

RRM2 Regulates Sensitivity to Sunitinib and PD‐1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway

Advancement of science, 2021
Renal cell carcinoma (RCC) is a malignant tumor of the kidneys. Approximately 70% of RCC cases are clear cell renal cell carcinoma with von Hippel–Lindau (VHL) gene mutation and activation of the vascular endothelial growth factor (VEGF) pathway ...
Wei Xiong, Bin Zhang, Haixin Yu, Liang Zhu, L. Yi, Xin Jin   +5 more
semanticscholar   +1 more source

Cáncer renal avanzado, perfiles para los nuevos tratamientos

Medicina Clínica Práctica, 2022
Resumen: El desarrollo de los nuevos agentes para el tratamiento del cáncer renal metastásico en la última década ha mejorado la calidad de vida y supervivencia de estos pacientes.
José Ignacio Abad Vivas-Pérez, Rocio Barrabino Martín, Joaquin Urda Romacho   +2 more
doaj   +1 more source